SL
VTVT icon

Siren LLC’s vTv Therapeutics VTVT Stock Holding History

Siren LLC’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.46M Hold
163,000
– – 0.18% 70
2025
Q4 		$6.52M Hold
163,000
– – 0.19% 71
2025
Q3 		$3.81M Buy
+163,000
New +$2.86M 0.15% 74

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Siren LLC's VTVT Position: Q1 2026 in Review

Siren LLC held its vTv Therapeutics (VTVT) position steady in Q1 2026 at 163,000 shares worth $6.46M. The position accounts for 0.18% of the portfolio, ranked #70.

Siren LLC first reported a position in VTVT in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.52M in Q4 2025. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Siren LLC held 163,000 shares of vTv Therapeutics worth $6.46M as of Q1 2026.
  • Siren LLC left its vTv Therapeutics share count unchanged in Q1 2026.
  • vTv Therapeutics made up 0.18% of Siren LLC's portfolio in Q1 2026, its #70 holding.
  • Siren LLC first reported a position in vTv Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Siren LLC's vTv Therapeutics position peaked at $6.52M in Q4 2025.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.